Bayer’s Medrad Centargo CT injection system is used to inject contrast media or contrast agents as part of CT imaging. Image credit: nitpicker / Shutterstock.

Bayer has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its multi-patient Medrad Centargo computed tomography (CT) injection system.

The injection system integrates with other Bayer products, especially the company’s high-volume CT suites. The company noted that the system is designed to minimise the preparation time to under two minutes and streamline data entry.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Contrast media injectors are used to inject contrast media or contrast agents to enhance the blood and perfusion in tissues. GlobalData expects the market for contrast media injectors to expand from being worth $1.64bn this year to exceed $2bn by 2030.

Bayer’s injection system has a piston-based technology allowing for a dual flow feature that allows for simultaneous delivery of contrast and saline solution. The system also has a snap-in patient line that allows for more effective patient rotation, with Bayer noting that the system is “ready for the next patient in less than 20 seconds”.

Bayer has already deployed the Medrad Centargo CT injection system in a hospital, Sunnybrook Health Sciences Centre in Toronto, Canada, in both acute care and outpatient settings. It is also equipped with an integrated barcode reader and Automated Documentation Software that simplifies the tracking and documentation of contrast media use and dose for each patient.

The injection system contains two valves in the patient line that minimise the risk of cross-contamination and air bubbles, as an additional feature.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Bayer has made considerable investments in expanding its radiological portfolio. In April, the company partnered with Google Cloud to develop and deploy “AI-powered healthcare applications with a clear focus on radiology”. The use of AI in medical imaging has increased in recent months.

Bayer also ventured into the crowded continuous glucose monitoring (CGM) market. In January, it partnered with Ireland-based Trinity Biotech to develop a CGM biosensor that eventually will be launched in China and India.